The vaccine uses an engineered protein from within the virus.
Gilead Sciences has backed George Washington University for the 18-month initiative.
Canadian researchers look at how non-neutralizing antibodies affect the virus.
Recent research shows the popular HIV treatment drug is a safe and highly effective treatment option for those also living with hepatitis B.
The drug company revealed promising long-term data at the 2022 Glasgow HIV conference, including news on cure development.
A government grant will fund an HIV-focused biomedical research space at Whitman-Walker Health.
Here’s the latest on a genetic editing technique with the potential to permanently eliminate HIV from the body.